ASHLEY DROEGE: Open Payments
NPI 1841726742 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 35 payments from 14 companies in 2025. Trend: 2023 $621 · 2024 $612 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Abbott Laboratories | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| PFIZER INC. | 3 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| ABBVIE INC. | 1 | $24 |
Products named: CAPLYTA, REXULTI, FREESTYLE LIBRE 3, INGREZZA, COBENFY, BREZTRI, NURTEC ODT, GARDASIL 9.
Industry payments across IL — which companies pay providers there.
